EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Domestic travel as a driver for the dissemination of mcr-1 in healthy travelers in China: a prospective, genomic epidemiological and gut microbiome study

Meina Wu iD, Yushun Chen, Minxuan Su, Hao Wu, Li Luo, Xiaojun Ao, Chanjing Zhao, Jingwei Shui, Shuan Wen, Jiehao Lin, Jieying Pu iD, Jianming Zeng und 8 weitere

Antimicrobial Agents and Chemotherapy · 03.06.2026 · 70 (6)

DOI: 10.1128/aac.01746-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 03.06.2026. Verfasst von Meina Wu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, The Second Clinical Medi…. Hauptthemen laut MEDLINE: Travel, Gastrointestinal Microbiome, Escherichia coli Proteins, Escherichia coli. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, National Major Science and Technology Projects of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global spread of plasmid-mediated colistin resistance gene mcr-1 poses a significant threat to public health. Although international travel is a known driver of antimicrobial resistance, the role of domestic travel in high-prevalence settings remains unclear. We conducted a prospective cohort study of 81 healthy volunteers traveling in China (June–September 2022). Fecal samples collected before and after travel were screened for mcr-1 -positive Escherichia coli (MCRPEC). Antimicrobial resistance genes (ARGs), virulence factors (VFs), plasmid replicons, and gut microbial dynamics were investigated using whole-genome sequencing and 16S rRNA sequencing. Risk factors were analyzed using logistic regression analysis. Of the 81 participants who were negative for mcr-1 at baseline, 12 (14.8%) acquired mcr-1 after travel. Acquisition was associated with residence near poultry farms (odds ratio [OR] = 5.9, P = 0.04) and diarrhea during travel (OR = 11.22, P = 0.027). MCRPEC exhibited marked genetic diversity comprising 10 sequence types and the carriage of additional 23 ARGs and nine adherence-associated VFs. mcr-1 was located on IncI2, IncX4, IncHI2, or IncP plasmids, with 91.7% ( n = 11) transferable in conjugation assays. Gut microbiome analysis showed increased α -diversity, but a stable community structure, indicating colonization without major disruption. Our study demonstrated that domestic travel in China substantially contributes to the dissemination of mcr-1 . Poultry exposure and gastrointestinal disturbances are key risk factors. Genetic diversity, plasmid transferability, and co-carriage of resistance and virulence determinants highlight the risk of onward spread. Antimicrobial resistance surveillance should extend beyond international travel and incorporate domestic mobility within a “One Health” framework.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TravelGastrointestinal MicrobiomeEscherichia coli ProteinsEscherichia coliHumansChinaProspective StudiesFemaleMalePlasmidsAdultAnti-Bacterial AgentsFecesDrug Resistance, BacterialAnimalsColistinEscherichia coli InfectionsRNA, Ribosomal, 16SMiddle AgedMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Escherichia colicolistin resistancedomestic travelmcr-1microbiomeplasmid

Substanzen

Escherichia coli ProteinsMCR-1 protein, E coliAnti-Bacterial AgentsColistinRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Clinical Laboratory/State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, The Second Clinical Medical College, Guangdong Provincial Hospital of Chinese Medicine, Guangz…
  • State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Research on Emergency in TCM, Guangzhou, China.
  • Department of Otolaryngology, Hospital of Honghe State Affiliated to Kunming Medical University, Southern Central Hospital of Yunnan Province, Mengzi, China.
  • Clinical Laboratory, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Clinical Laboratory, Kiang Wu Hospital, Macau, China.

ORCID-Profile: Meina Wu, Jieying Pu, Lingqing Xu, Cha Chen, Cong Shen

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • National Major Science and Technology Projects of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Wu, M., Chen, Y., Su, M., Wu, H., Luo, L., Ao, X., Zhao, C., Shui, J., Wen, S., Lin, J., Pu, J., Zeng, J., Jiang, Y., Ng, H., Zhang, Z., Hu, M., Huang, B., Xu, L., Chen, C., & Shen, C. (2026). Domestic travel as a driver for the dissemination of mcr-1 in healthy travelers in China: a prospective, genomic epidemiological and gut microbiome study. Antimicrobial Agents and Chemotherapy, 70(6). https://doi.org/10.1128/aac.01746-25

Vancouver

Wu M, Chen Y, Su M, Wu H, Luo L, Ao X, et al. Domestic travel as a driver for the dissemination of mcr-1 in healthy travelers in China: a prospective, genomic epidemiological and gut microbiome study. Antimicrobial Agents and Chemotherapy. 2026;70(6). doi:10.1128/aac.01746-25

BibTeX
@article{Wu2026,
  author = {Wu, Meina and Chen, Yushun and Su, Minxuan and Wu, Hao and Luo, Li and Ao, Xiaojun and Zhao, Chanjing and Shui, Jingwei and Wen, Shuan and Lin, Jiehao and Pu, Jieying and Zeng, Jianming and Jiang, Yueting and Ng, Hoiman and Zhang, Zhongde and Hu, Mingli and Huang, Bin and Xu, Lingqing and Chen, Cha and Shen, Cong},
  title = {Domestic travel as a driver for the dissemination of mcr-1 in healthy travelers in China: a prospective, genomic epidemiological and gut microbiome study},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {6},
  doi = {10.1128/aac.01746-25}
}
Kostenlos starten →